会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • Method For The Preparation Of X-Ray Amorphous Or Weakly Crystalline Metal Oxide Fluorides And New Uses Thereof
    • 用于制备X射线非晶态或弱结晶金属氧化物氟化物的方法及其新用途
    • US20080274037A1
    • 2008-11-06
    • US11720796
    • 2005-12-05
    • Udo GrossErhard KemnitzStephan Ruediger
    • Udo GrossErhard KemnitzStephan Ruediger
    • C01F7/50C01B11/24
    • C01F5/28B01J27/12B01J27/125B01J27/138B01J35/002B01J35/1019C01B9/08C01F7/50C01P2002/02C01P2006/12C01P2006/14C03C17/22C03C2217/285
    • The present invention is related to a method for preparing an X-ray amorphous or weakly crystalline metal oxide fluoride of a composition represented by the formula Ma+ObFc comprising the steps of b) providing a precursor, whereby the precursor is a fluorinated metal compound having a composition which is represented by the formula Ma+F(a−d)BdLxb) converting the precursor into an metal oxide/hydroxide fluoride; and c) calcinating the metal oxide/hydroxide fluoride having the formula Ma+OcHfFc to generate the X-ray amorphous or weakly crystalline metal oxide fluoride of the formula Ma+ObFc, whereby M is selected from the group comprising metals of the first, second, third and fourth main group and any subgroup of the periodic table; B is a group or an anion which is selected from the group comprising alkoxide, enolates, alkyl, chloride, bromide, iodide, nitrate, and organic acid anions; B is preferably an alkoxy group; L is a solvent other than water; a is any integer of 1, 2, 3, 4, 5 or 6, preferably 2 or 3; and b and c are any numbers obeying the formula b/2+c=a, and c is 0.1b to 10b; d is a number between 0 and 0.8a, preferable between 0.1 and 0.3a; e is (a−c+f)/2; f is a number between 0 and (a−c); and x is between 0 and 6.
    • 本发明涉及一种制备由下式表示的组合物的X射线无定形或弱结晶金属氧化物氟化物的方法: c)包括以下步骤:b)提供前体,由此所述前体是具有由下式表示的组成的氟化金属化合物:(a) b)将前体转化为金属氧化物/氢氧化物氟化物; 和c)将具有下式的金属氧化物/氢氧化物氟化物煅烧:将式M a -O + 产生式M a O b O b C c C的X射线无定形或弱结晶金属氧化物氟化物,其中M选自 包括第一,第二,第三和第四主族的金属和周期表的任何亚组; B是选自醇盐,烯醇化物,烷基,氯化物,溴化物,碘化物,硝酸盐和有机酸阴离子的基团或阴离子; B优选为烷氧基; L是水以外的溶剂; a是1,2,3,4,5或6,优选2或3的整数; b和c是符合公式b / 2 + c = a的任何数字,c是0.1b〜10b; d是0和0.8a之间的数,优选在0.1和0.3a之间; e为(a-c + f)/ 2; f是0和(a-c)之间的数字; x在0和6之间。
    • 10. 发明授权
    • Pharmacological composition for topical administration
    • 用于局部给药的药理组合物
    • US5686102A
    • 1997-11-11
    • US674851
    • 1996-07-03
    • Udo GrossJoachim RodingKlaus StanzlLeonhard Zastrow
    • Udo GrossJoachim RodingKlaus StanzlLeonhard Zastrow
    • A61K8/14A61K8/70A61K9/127A61Q19/00A61K7/00
    • A61K8/14A61K8/70A61K9/0014A61K9/127A61Q19/00Y10S514/944Y10S514/969
    • The invention relates to pharmaceutical compositions which are incorporated into the skin with the aid of novel microaggregates as carriers. The object of the invention is to make available pharmacological active compounds in a biologically and chemically inert carrier for therapeutic and diagnostic administration to the skin or for systemic administration, and in this way to make deeper penetration into the skin or transdermal transport possible. According to the invention, this is effected by means of a pharmaceutical composition for topical administration, which contains asymmetric lamellar aggregates, consisting of phospholipids, pharmacological active compounds and fluorocarbons or fluorocarbon mixtures, the proportion of fluorocarbon being in the range from 1 to 100% weight/volume, in a pharmaceutical excipient which is suitable for topical administration. Preparation is effected by emulsification of the appropriate constituents and use in ointments, creams, lotions, pastes, gels, powders or on a dressing or plaster or by means of a spray.
    • 本发明涉及借助于新的微团聚体作为载体并入皮肤中的药物组合物。 本发明的目的是在生物和化学惰性的载体中制备可用的药理学活性化合物,用于治疗和诊断给予皮肤或全身给药,并且以这种方式使得能够更深入地渗入皮肤或透皮传递。 根据本发明,这是通过用于局部给药的药物组合物实现的,其包含由磷脂,药理活性化合物和碳氟化合物或碳氟化合物混合物组成的不对称层状聚集体,碳氟化合物的比例在1至100% 重量/体积,适用于局部给药的药物赋形剂。 制备通过乳化适当的组分并用于软膏,乳膏,洗剂,糊剂,凝胶,粉末或敷料或膏药或通过喷雾剂进行。